The U.S. Food and Drug Administration (FDA) has approved GSK’s Nucala (mepolizumab) as an add-on maintenance treatment for adult patients with chronic obstructive pulmonary disease (COPD) with ...

Moving beyond traditional methods of observing thinly sliced and stained cancer tissues, a collaborative international ...